# Predictive Nomogram of CRPC

> **NCT03177551** · — · UNKNOWN · sponsor: **Tianjin Medical University Second Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Castration-resistant Prostate Cancer
- Metastatic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03177551
- **Lead sponsor:** Tianjin Medical University Second Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-04
- **Primary completion:** 2019-09
- **Final completion:** 2020-05
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2018-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03177551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03177551, "Predictive Nomogram of CRPC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03177551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*